Takeda Pharmaceutical Company Limited approved the appointment of John Maraganore as External Director, effective from June 29, 2022, Koji Hatsukawa as Head of Audit and Supervisory Committee, Yoshiaki Fujimori as Audit and Supervisory Committee Member, Emiko Higashi as Audit and Supervisory Committee Member, Kimberly A. Reed as External Director, Audit and Supervisory Committee Member, Michel Orsinger as Compensation committee Member, Masami Iijima, Chairperson of Nomination committee and Yoshiaki Fujimori as Nomination committee, effective from June 29, 2022.